Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab.
Geoffrey Alan WatsonEnrique Sanz-GarciaWen-Jiang ZhangZhihui Amy LiuSy Cindy YangBen WangShaofeng LiuShawn KubliHal BermanThomas PfisterSofia GentaAnna SpreaficoAaron R HansenPhilippe L BedardStéphanie LheureuxAlbiruni Abdul RazakDave CesconMarcus O ButlerWei XuTak W MakLillian L SiuEric X ChenPublished in: Journal for immunotherapy of cancer (2022)
NCT03702309.